<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CE562D3D-45D5-45B3-99FF-A81611187A1C"><gtr:id>CE562D3D-45D5-45B3-99FF-A81611187A1C</gtr:id><gtr:name>Veterinary Services</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46F221A3-C017-4ED6-A406-A32C62E677E2"><gtr:id>46F221A3-C017-4ED6-A406-A32C62E677E2</gtr:id><gtr:name>Nijmegen Center for Molecular Life Sciences (NCMLS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B"><gtr:id>22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B</gtr:id><gtr:name>University of Ulm</gtr:name><gtr:address><gtr:line1>Albert Einstein Allee 5</gtr:line1><gtr:line4>Ulm</gtr:line4><gtr:postCode>89081</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AD1B5C1D-39E1-4A1F-A58F-D5F2DE64FE7F"><gtr:id>AD1B5C1D-39E1-4A1F-A58F-D5F2DE64FE7F</gtr:id><gtr:name>Innsbruck Medical University</gtr:name><gtr:address><gtr:line1>Christoph-Probst-Platz 1</gtr:line1><gtr:line2>Innrain 52</gtr:line2><gtr:postCode>A-6020</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DD1F1403-9928-4563-8E48-326ACF87C706"><gtr:id>DD1F1403-9928-4563-8E48-326ACF87C706</gtr:id><gtr:name>University Hospital of Wales</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CE562D3D-45D5-45B3-99FF-A81611187A1C"><gtr:id>CE562D3D-45D5-45B3-99FF-A81611187A1C</gtr:id><gtr:name>Veterinary Services</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46F221A3-C017-4ED6-A406-A32C62E677E2"><gtr:id>46F221A3-C017-4ED6-A406-A32C62E677E2</gtr:id><gtr:name>Nijmegen Center for Molecular Life Sciences (NCMLS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B"><gtr:id>22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B</gtr:id><gtr:name>University of Ulm</gtr:name><gtr:address><gtr:line1>Albert Einstein Allee 5</gtr:line1><gtr:line4>Ulm</gtr:line4><gtr:postCode>89081</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AD1B5C1D-39E1-4A1F-A58F-D5F2DE64FE7F"><gtr:id>AD1B5C1D-39E1-4A1F-A58F-D5F2DE64FE7F</gtr:id><gtr:name>Innsbruck Medical University</gtr:name><gtr:address><gtr:line1>Christoph-Probst-Platz 1</gtr:line1><gtr:line2>Innrain 52</gtr:line2><gtr:postCode>A-6020</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD1F1403-9928-4563-8E48-326ACF87C706"><gtr:id>DD1F1403-9928-4563-8E48-326ACF87C706</gtr:id><gtr:name>University Hospital of Wales</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F7F4370D-D99C-4DC9-A62C-DAA8C08ACD7B"><gtr:id>F7F4370D-D99C-4DC9-A62C-DAA8C08ACD7B</gtr:id><gtr:firstName>Simon John</gtr:firstName><gtr:surname>Clark</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/336B2F88-5F05-4D8F-9E01-0345906FD903"><gtr:id>336B2F88-5F05-4D8F-9E01-0345906FD903</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Nicholas</gtr:otherNames><gtr:surname>Bishop</gtr:surname><gtr:orcidId>0000-0001-7937-7932</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3E049216-D7C5-40EE-929B-4B642DABE478"><gtr:id>3E049216-D7C5-40EE-929B-4B642DABE478</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:surname>Day</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0900538"><gtr:id>366854C9-BEAB-4F1B-88C0-0A0F78EEB829</gtr:id><gtr:title>Host tissue recognition by complement factor H in the human eye: mapping changes with age and in AMD</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900538</gtr:grantReference><gtr:abstractText>Over half of blindness in the UK is caused by age-related macular degeneration (AMD), with about 50 million people affected worldwide. AMD is a disease that damages the central part of the retina (called the macula) and leads to central vision loss. There is mounting evidence that the risk of developing this disease is strongly influenced by our genes. Recent studies revealed that a common variant in one particular gene (known as Complement Factor H or CFH for short) strongly increases the risk of developing AMD. This variant (called the Y402H polymorphism) is present in about 35% of people of European decent and it results in a small, but significant, change in the CFH protein that alters its functional properties. We have recently made an important discovery that the ?Y? and ?H? forms of CFH (normal and disease-causing, respectively) have different abilities to recognise carbohydrate molecules in the eye. This may influence the localisation of the CFH protein, which is likely to be important to the cause and development of AMD since CFH is part of our immune system that distinguishes healthy from diseased tissues. If the CFH protein is not present in the correct location then a disruption to the function of the immune system would lead to tissue damage. 
We have proposed that AMD may result from age-related changes in the carbohydrate molecules within the eye, which we believe would influence CFH location and function. One aim of this research project is to test this idea by analysing eye tissues from donors of different ages (supplied by the Manchester Eye Bank) in a wide range of experiments. In addition to normal eye tissues we will also examine AMD-affected eyes. These studies are possible due to the molecular tools we have developed that allow us to look (using microscopy) at CFH-binding sites in human tissues. Our own expertise in Manchester (for example in AMD, the CFH protein and carbohydrate chemistry) will be complemented by a network of scientific collaborators (in the UK and USA) providing access to specialised biochemicals and cutting-edge technologies.
Overall these studies are likely to lead to a greater understanding of the causes of AMD and may allow the development of new therapeutic strategies for treating this disease.</gtr:abstractText><gtr:technicalSummary>Age-related macular degeneration (AMD) is the leading cause of blindness in the western world, where the Y402H polymorphism of complement factor H (CFH) is a major risk factor for disease onset/progression. CFH is a regulator of the complement system and there is strong evidence that the dysregulation of complement is an early step in AMD. Previously we reported that the 402H and 402Y variants of CFH interact differentially with sulphated glycosaminoglycans (GAGs). We hypothesised that this functional difference may modify the tissue-binding properties of CFH and could contribute to the pathology of AMD. Recently we have found that these variants (studied in isolation in a recombinant construct and in the context of full-length CFH) recognise different sites within macula tissue of normal human eyes. There are substantially fewer binding sites for the AMD-associated 402H than the 402Y variant within the Bruch?s membrane, i.e. the site where particulate matter (drusen), associated with central vision loss, accumulates. Importantly, our data indicate that binding sites in human macula for CFH are comprised mainly of the GAGs heparan sulphate (HS) and dermatan sulphate (DS), i.e. structurally diverse matrix polysaccharides.
We, therefore, hypothesise that age-related changes in GAG structure within the macula combined with the different GAG-binding properties of the 402H/402Y proteins (i.e. the genetic predisposition) make a major contribution to the pathology of AMD. The aims of this study are to: 1) test this hypothesis by determining how the CFH-binding sites in macula tissue change with age and disease; 2) undertake a detailed analysis of the different GAG structures that mediate binding to the 402H/402Y variants, and 3) characterise the GAG-binding properties of different regions of CFH. Specifically, we will characterise human macula (by immunofluorescence) for 402H- and 402Y-binding sites (and endogenous CFH) from a wide age range of genotyped donors compared to AMD tissues (i.e. containing drusen); the relative contributions of different regions of CFH will be determined. Furthermore, we will identify the HS/DS structures present in macula (e.g. by mass spectrometry), characterise the CFH-GAG interactions using a range of biophysical techniques, and determine the role of GAGs in modulating CFH activity.
These studies will help determine the molecular basis of host tissue recognition in the macula during normal aging and in AMD. We anticipate that this will lead to a greater understanding of the pathology/progression of AMD and may allow the development of new therapeutic strategies for treating this disease.</gtr:technicalSummary><gtr:fund><gtr:end>2012-10-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>409421</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Sciences Division</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Role of complement factor H in AMD.</gtr:description><gtr:id>6C8F7633-AD56-4461-8EA9-A9787327E444</gtr:id><gtr:impact>I primary paper in J. Biol. Chem. (2010).
Abstract/poster at BSMB Spring Meeting: &amp;quot;Vascular Matrix in Health &amp;amp; Disease&amp;quot;, Manchester, UK (2010).
Abstract/poster at ARVO 2010 conference, Fort Lauderdale, Florida, USA (2010).
Abstract/poster at BSMB Autumn Meeting &amp;quot;Inflammation meets matrix biology&amp;quot;, UEA, Norwich (2010).
Abstract/poster at 13th European Meeting on Complement in Human Disease, Leiden (2011).
Abstract/poster at Get Connected 2, Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, UK (2011).
Abstract/poster at 7th International Conference on Proteoglycans, Sydney, Australia (2011).
Abstract/poster/talk presented at ARVO 2012, Fort Lauderdale, USA. 
Primary publication submitted to J. Immunol.</gtr:impact><gtr:partnerContribution>Provision of reagents to support our research.Provision of reagents to support our research.</gtr:partnerContribution><gtr:piContribution>We used reagents provided by these collaborators in our research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ulm</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>The role of FHL-1 in AMD</gtr:description><gtr:id>47D15D38-CB7D-442A-99DB-2921B4B5657D</gtr:id><gtr:impact>Clark et al. (2014) J. Immunol.</gtr:impact><gtr:partnerContribution>Collaborator provided research reagent.</gtr:partnerContribution><gtr:piContribution>Used reagent supplied by collaborator.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry Edinburgh</gtr:department><gtr:description>The heparin-binding properties of complment factor H.</gtr:description><gtr:id>38C3177D-7433-425A-B125-23B0BA9AA8AB</gtr:id><gtr:impact>Abstract/poster at BSMB Autumn Meeting &amp;quot;Inflammation meets matrix biology&amp;quot;, UEA, Norwich (2010).
Abstract/poster at 13th European Meeting on Complement in Human Disease, Leiden (2011).
Abstract/poster at Get Connected 2, Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, UK (2011).
Abstract/poster at 7th International Conference on Proteoglycans, Sydney, Australia (2011).
Abstract/poster/talk presented at ARVO 2012, Fort Lauderdale, USA. 
Primary publication submitted to J. Immunol.</gtr:impact><gtr:partnerContribution>Provision of reagents to enable our research.</gtr:partnerContribution><gtr:piContribution>We have used reagents provider by this collaboration to enable our research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nijmegen Center for Molecular Life Sciences (NCMLS)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Mapping of glycosaminoglycans in human retina, choroid and sclera.</gtr:description><gtr:id>1577BBE1-B943-4E01-A812-012F4D42FC0F</gtr:id><gtr:impact>I primary paper in IOVS (2011).
Abstract/poster at ARVO 2010 conference, Fort Lauderdale, Florida, USA (2010).</gtr:impact><gtr:partnerContribution>The collaborators have provided reagents to aid our research.</gtr:partnerContribution><gtr:piContribution>We have used the reagents supplied to aid our research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Innsbruck Medical University</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Department of Hygiene, Microbiology and Social Medicine</gtr:department><gtr:description>Role of complement factor H in host recognition.</gtr:description><gtr:id>328CF038-8C41-48A1-B94D-2E794C48CB26</gtr:id><gtr:impact>Abstract/poster at13th European Meeting on Complement in Human Disease, Leiden (2011). 
Abstract/poster at Get Connected 2, Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, UK (2011).
Abstract/poster at 7th International Conference on Proteoglycans, Sydney, Australia (2011).
Abstract/poster at ARVO 2012, Fort Lauderdale, USA.</gtr:impact><gtr:partnerContribution>They have provided research materials to aid the research.</gtr:partnerContribution><gtr:piContribution>We have performed experiments using materials provided by the collaborators.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital of Wales</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medical Biochemistry and Immunology</gtr:department><gtr:description>Role of complement factor H in AMD.</gtr:description><gtr:id>E614E749-2E41-403B-A4EC-818B2FCF43F4</gtr:id><gtr:impact>I primary paper in J. Biol. Chem. (2010).
Abstract/poster at BSMB Spring Meeting: &amp;quot;Vascular Matrix in Health &amp;amp; Disease&amp;quot;, Manchester, UK (2010).
Abstract/poster at ARVO 2010 conference, Fort Lauderdale, Florida, USA (2010).
Abstract/poster at BSMB Autumn Meeting &amp;quot;Inflammation meets matrix biology&amp;quot;, UEA, Norwich (2010).
Abstract/poster at 13th European Meeting on Complement in Human Disease, Leiden (2011).
Abstract/poster at Get Connected 2, Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, UK (2011).
Abstract/poster at 7th International Conference on Proteoglycans, Sydney, Australia (2011).
Abstract/poster/talk presented at ARVO 2012, Fort Lauderdale, USA. 
Primary publication submitted to J. Immunol.</gtr:impact><gtr:partnerContribution>Provision of reagents to support our research.Provision of reagents to support our research.</gtr:partnerContribution><gtr:piContribution>We used reagents provided by these collaborators in our research.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>&quot;The Body Experience&quot;, Manchester Museum</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6297C8C7-8F97-41EE-9A5B-BCE7CD19220D</gtr:id><gtr:impact>Approximately 1900 members of the public visited the one-day event at the Manchester Museum, which highlighted research conducted on different parts of the body (including eyes) at the University of Manchester.

Public feedback revealed strong interest in this, and the possibility of future similar events.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release accompanying publication of research paper.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A645CAFA-AB9D-4BC0-BE8B-62BC3496C52A</gtr:id><gtr:impact>Press release. Scientists discover new cause of blindness (21st September 2010): http://www.manchester.ac.uk/aboutus/news/display/?id=6123


Story covered by New Scientist (News In Brief: Leading Cause of Blindness Solved, 2nd October 2010):</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article by Paul Bishop for Macular Society magazine Digest entitled &quot;Establishing a national eye tissue archive&quot;</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>272355B8-359A-47A2-9040-9F802724E139</gtr:id><gtr:impact>Article on the importance of donor eye tissue for research into AMD and the establishment of Manchester Eye Tissue Repository</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at Macular Society Top Doctor event 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>520C4855-9BB9-49AD-BD0A-960EDEF712BE</gtr:id><gtr:impact>Invited speaker at the Macular Society's 'Top Doctor' event 2015. There was much discussion with the lay audience of mainly elderly individuals, some of who suffer from AMD, and interaction both during and after the talks.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Elizabeth Thomas Seminar 2016. Presentation by Paul Bishop entitled &quot;Eye Banking/Repository - How does that contribute to Research in Macular Diseases in the UK?&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>76B11906-E5C7-42E6-9ACA-D174D99CE135</gtr:id><gtr:impact>Raised awareness of Manchester Eye tissue Repository and subsequently requests have been made for donor eye tissue for research.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release on publication in  Journal of Immunology</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C05EF6F8-CEED-4FDC-82CF-C76BC502F850</gtr:id><gtr:impact>The press release was picked up by &amp;gt;10 online news fora, including Science Daily and Science Codex.

None as yet.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url> http://www.manchester.ac.uk/aboutus/news/display/?id=9561</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;Wellcome to the Matrix&quot; open days.</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>574D5461-E143-47A5-ACC4-7A6998F40ACF</gtr:id><gtr:impact>30 GCSE pupils (from local Manchester schools) attended each day over 5 or 3 days in 2010 and 2011, respectively. This included a tour of the research facilities and a wide range of participatory activities (e.g. model building) on the research carried out at the Wellcome Trust Centre for Cell-Matrix Research.

Positive feedback on our research environment and increased awareness of the role scientists and opportunities for careers in science.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Summer Science Exhibition</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B37D3D77-8195-4090-A124-E50C19F600C2</gtr:id><gtr:impact>This event brought the importance of studying sugars to the public, schools, politicians and policymakers; ~10,000 visitors attended this event.

Unclear as yet.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://sse.royalsociety.org/2013/exhibits/sweet-complexity/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Norfolk &amp; Norwich University Hospital Regional Study Day, Bury St. Edmunds, UK.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>40F389AA-9A16-4A0A-9235-811CBD6B4476</gtr:id><gtr:impact>~100 Ophthalmology health professionals from Norfolk/Suffolk attended this Regional Study Day.

There was considerable interest in our on-going work on AMD.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on Insight Radio (RNIB)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B303A89D-F609-46CB-80A7-BD3DB41E0F06</gtr:id><gtr:impact>Radio interview following award of Clinical Research Fellowship, which was based on the research carried out in this grant.

This interview was part of AMD awareness week with the aim of increasing public knowledge of this major form of blindness.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at Eyecare 2017, Glasgow.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C89BA9F2-01A3-4E75-B6CD-CE383E62C431</gtr:id><gtr:impact>Simon J Clark gave a talk about new treatments being developed for Dry AMD to eye care health professionals and patients. Official feedback was collected and provided (please see URL provided below). Briefly, the talk was the third highest attended talk of the two day conference (80); where 67% of the audience ranked it as &amp;quot;Excellent&amp;quot;, and a further 30% as &amp;quot;Good&amp;quot;. Dr. Clark also took part in the most attended session of the conference - the 'Ask the Experts' Q &amp;amp; A panel.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://gallery.mailchimp.com/75705ffde3df8421f476475ac/files/94884fc5-64b5-49cb-9a55-ad0630a6b7ca/Eyecare_2017_Feedback_FINAL.pdf</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A-level study day, Manchester Museum</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2655B93D-E58D-4A44-BC24-86FAF48B97CC</gtr:id><gtr:impact>70 A-level students from Manchester schools attended lectures/workshop over two days at the Manchester Museum.

Post event surveys indicated that a large percentage (~80%) were more interested in the possibility of doing future scientific research than before attending. As a direct consequence of this event one student from Manchester Grammar School spent one week's work experience in the laboratory on this specific project.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker, Woman's Institute Science Club, Grazely, Berkshire.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B688E24F-589E-466C-95C5-7900B2EE4652</gtr:id><gtr:impact>Simon J Clark was invited to talk about AMD, its affects on people and the economy and new treatments being developed that will make a difference in the future. He also raised money for the charity Fight for Sight.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>127983</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Univerity of Manchester and A*STAR PhD Studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>University of Manchester</gtr:fundingOrg><gtr:id>AB349843-1E24-48CD-85C5-E0F9FEC7A7B1</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fulbright Scholarship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>4F77A777-314A-4AD5-B5A1-EB3CCCB937A7</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>169809</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>46689494-7770-4DED-B7FB-9A952989A975</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>179398</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Fellowship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>622887D2-3DEC-4C1E-A33D-63B42921DEA9</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110274</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>152E5823-2918-4CA1-AC93-6E42D61EF7C1</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>85502</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Stepping Stones Research Fellowship</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>University of Manchester</gtr:fundingOrg><gtr:id>1977D556-BF19-4A4D-A97F-1AA5A6BDC545</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14547</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fight for Sight/National Eye Research Centre Small Grant Award</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>05919091-819D-4895-AECD-22323A31B993</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>664961</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Career Development Award</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K024418/1</gtr:fundingRef><gtr:id>677D1426-689B-497F-906C-9E4703E1762E</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>217343</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Macular Society</gtr:fundingOrg><gtr:id>3886FD78-4009-49E9-943C-7F97F84DB452</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>480344</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FBF6DCF0-AD6D-4F17-ACE7-18152C2EF9FB</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We are building up a collection of human eye tissue (e.g. from donors of different ages) to support our work on Age-related Macular Degeneration.</gtr:description><gtr:id>A026DF43-CF15-4952-9649-DB986FDDC92A</gtr:id><gtr:impact>6 primary papers (Clark et al., 2010 J. Biol. Chem.; Clark et al., 2011 IOVS; Keenan et al.., 2012 IOVS; Clark et al., 2013 J. Immunol.;Clark et al., 2014; Keenan et al., 2014 IOVS). Several papers are in preparation.

Invited to speak at Complement UK Symposium (Newcastle, UK) 2013; Annual Meeting of Glycoren consortium 2013 (Leiden, The Netherlands); ARVO 2014 (Orlando, USA).</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Human eye collection</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have identified a novel disease mechanism for Age-related Macular Degeneration (AMD).</gtr:description><gtr:id>6E7A3DFF-8D1E-457A-94BF-F6A1559B9EA8</gtr:id><gtr:impact>3 primary papers (Clark et al., 2010 J. Biol. Chem; Clark et al. 2013 J. Immunol.; Keenan et al. 2014 IOVS), 4 review articles (Clark et al., 2010 Biochem. Soc. Trans; Day et al. Expert Reviews Ophthalmology; Clark et al., 2013 Frontiers in Immunology; Langford-Smith et al. 2014 J Innate Immunity) and 2 press releases.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Identification of novel disease mechanism for Age-related Macular Degeneration (AMD).</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Developed protocol for expression, refolding and purification of human versican G1 domain.</gtr:description><gtr:id>B816A82B-F858-428B-99BF-799A7E0C7DFE</gtr:id><gtr:impact>License agreement (Protocol for expression, refolding and purification of versican G1 domain) between MRCT and University of Manchester (February 2011). MRCT licensed this technology to Echelon Biosciences Inc. (July 2011). This reagent is available from Echelon Biosciences:

https://echelon-inc.com/index.php?module=Products&amp;amp;func=view&amp;amp;category_id=10127</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>License agreement with Echelon Biosciences Inc. for method to make verscian G1 domain</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD5FDA85-3A22-4C8E-B817-4AF22FA5B25C"><gtr:id>AD5FDA85-3A22-4C8E-B817-4AF22FA5B25C</gtr:id><gtr:title>Enrichment of Bruch's Membrane from Human Donor Eyes.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a5dbdcface494ef6a1a386951bda59d4"><gtr:id>a5dbdcface494ef6a1a386951bda59d4</gtr:id><gtr:otherNames>McHarg S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D4AEC4F9-54BF-4D74-836F-416578330D31"><gtr:id>D4AEC4F9-54BF-4D74-836F-416578330D31</gtr:id><gtr:title>Role of Factor H and Related Proteins in Regulating Complement Activation in the Macula, and Relevance to Age-Related Macular Degeneration.</gtr:title><gtr:parentPublicationTitle>Journal of clinical medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6296b4266e4f550f4b387140ab8da49e"><gtr:id>6296b4266e4f550f4b387140ab8da49e</gtr:id><gtr:otherNames>Clark SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2077-0383</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5621894D-47A9-49DA-B670-CAF2AF122B4C"><gtr:id>5621894D-47A9-49DA-B670-CAF2AF122B4C</gtr:id><gtr:title>Permeability of Bruch's membrane to complement proteins: Implications for translational medicine in AMD</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6296b4266e4f550f4b387140ab8da49e"><gtr:id>6296b4266e4f550f4b387140ab8da49e</gtr:id><gtr:otherNames>Clark SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/267758E6-C7B2-41E7-BADB-29828036BB53"><gtr:id>267758E6-C7B2-41E7-BADB-29828036BB53</gtr:id><gtr:title>A coupled hydrodynamic-structural model of the M4 wave energy converter</gtr:title><gtr:parentPublicationTitle>Journal of Fluids and Structures</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea00f36bfab1dd4ccdd4f5c72d2c7547"><gtr:id>ea00f36bfab1dd4ccdd4f5c72d2c7547</gtr:id><gtr:otherNames>Eatock Taylor R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F0915FC4-D97F-4CB9-9A34-73BFAC7B894B"><gtr:id>F0915FC4-D97F-4CB9-9A34-73BFAC7B894B</gtr:id><gtr:title>Understanding the molecular basis of age-related macular degeneration and how the identification of new mechanisms may aid the development of novel therapies</gtr:title><gtr:parentPublicationTitle>Expert Review of Ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a141da9f9b2f40afac8c257b8bad75e1"><gtr:id>a141da9f9b2f40afac8c257b8bad75e1</gtr:id><gtr:otherNames>Day A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8C24ACC4-3799-4E2A-8093-5BFE157CBA29"><gtr:id>8C24ACC4-3799-4E2A-8093-5BFE157CBA29</gtr:id><gtr:title>Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6296b4266e4f550f4b387140ab8da49e"><gtr:id>6296b4266e4f550f4b387140ab8da49e</gtr:id><gtr:otherNames>Clark SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7E5EFEE9-8D3E-4B4C-9ACA-DA22870AB3D6"><gtr:id>7E5EFEE9-8D3E-4B4C-9ACA-DA22870AB3D6</gtr:id><gtr:title>Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6296b4266e4f550f4b387140ab8da49e"><gtr:id>6296b4266e4f550f4b387140ab8da49e</gtr:id><gtr:otherNames>Clark SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/93081B7D-71B2-461B-8C24-BA061F8A2244"><gtr:id>93081B7D-71B2-461B-8C24-BA061F8A2244</gtr:id><gtr:title>Mapping the differential distribution of proteoglycan core proteins in the adult human retina, choroid, and sclera.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5a7c80631b2c5d8d3651ac260b0e6e7f"><gtr:id>5a7c80631b2c5d8d3651ac260b0e6e7f</gtr:id><gtr:otherNames>Keenan TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41B6B68C-7EA9-4E6A-828C-20F3B119C4ED"><gtr:id>41B6B68C-7EA9-4E6A-828C-20F3B119C4ED</gtr:id><gtr:title>Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6296b4266e4f550f4b387140ab8da49e"><gtr:id>6296b4266e4f550f4b387140ab8da49e</gtr:id><gtr:otherNames>Clark SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9F14DA5F-00E9-4C28-B4DC-833C4629C249"><gtr:id>9F14DA5F-00E9-4C28-B4DC-833C4629C249</gtr:id><gtr:title>Age-related macular degeneration and the role of the complement system.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a5dbdcface494ef6a1a386951bda59d4"><gtr:id>a5dbdcface494ef6a1a386951bda59d4</gtr:id><gtr:otherNames>McHarg S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2843AA5C-16CF-4D50-AC73-DC2C1C3904B9"><gtr:id>2843AA5C-16CF-4D50-AC73-DC2C1C3904B9</gtr:id><gtr:title>Age-dependent changes in heparan sulfate in human Bruch's membrane: implications for age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5a7c80631b2c5d8d3651ac260b0e6e7f"><gtr:id>5a7c80631b2c5d8d3651ac260b0e6e7f</gtr:id><gtr:otherNames>Keenan TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A27CF1C-A638-4B43-9985-5BF994E932EE"><gtr:id>9A27CF1C-A638-4B43-9985-5BF994E932EE</gtr:id><gtr:title>Complement factor H in host defense and immune evasion.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2779340c9560dc62c5003cab48c5c692"><gtr:id>2779340c9560dc62c5003cab48c5c692</gtr:id><gtr:otherNames>Parente R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6FC5CC9D-37B8-4EF1-AAB7-BD1585B4E365"><gtr:id>6FC5CC9D-37B8-4EF1-AAB7-BD1585B4E365</gtr:id><gtr:title>The proteoglycan glycomatrix: a sugar microenvironment essential for complement regulation.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6296b4266e4f550f4b387140ab8da49e"><gtr:id>6296b4266e4f550f4b387140ab8da49e</gtr:id><gtr:otherNames>Clark SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1646D822-4118-4232-90CE-9F56557A411D"><gtr:id>1646D822-4118-4232-90CE-9F56557A411D</gtr:id><gtr:title>The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?</gtr:title><gtr:parentPublicationTitle>Journal of innate immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cb8b2b4a5dc828befb7037b8e2b9544a"><gtr:id>cb8b2b4a5dc828befb7037b8e2b9544a</gtr:id><gtr:otherNames>Langford-Smith A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1662-811X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E0B85CC4-23A6-4888-B618-2B97B16A8C9C"><gtr:id>E0B85CC4-23A6-4888-B618-2B97B16A8C9C</gtr:id><gtr:title>Complementing the Sugar Code: Role of GAGs and Sialic Acid in Complement Regulation.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cb8b2b4a5dc828befb7037b8e2b9544a"><gtr:id>cb8b2b4a5dc828befb7037b8e2b9544a</gtr:id><gtr:otherNames>Langford-Smith A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6EA773CB-A7F6-4A86-9CF9-6277EC85FA94"><gtr:id>6EA773CB-A7F6-4A86-9CF9-6277EC85FA94</gtr:id><gtr:title>Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6296b4266e4f550f4b387140ab8da49e"><gtr:id>6296b4266e4f550f4b387140ab8da49e</gtr:id><gtr:otherNames>Clark SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D33277B-3C55-4E0D-9B39-0092A379A081"><gtr:id>7D33277B-3C55-4E0D-9B39-0092A379A081</gtr:id><gtr:title>Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6296b4266e4f550f4b387140ab8da49e"><gtr:id>6296b4266e4f550f4b387140ab8da49e</gtr:id><gtr:otherNames>Clark SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900538</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>